Trastuzumab Description and Brand Names

Trastuzumab administration during pregnancy: an update trastuzumab trastuzumab Early breast cancer Herceptin is indicated for the treatment of patients with HER2-positive early breast cancer: following surgery trastuzumab Trastuzumab is a monoclonal antibody targeted against the HER2 tyrosine kinase receptor The majority of patients with metastatic breast

trastuzumab Trastuzumab side effects · heart problems; · nausea, diarrhea, weight loss; · headache; · trouble sleeping, feeling tired; · low blood cell